Anti-Mouse/Human IL-5 [Clone TRFK5] — APC
Anti-Mouse/Human IL-5 [Clone TRFK5] — APC
Product No.: I-1313
- -
- -
Product No.I-1313 Clone TRFK5 Target IL-5 Formats AvailableView All Product Type Recombinant Monoclonal Antibody Alternate Names BCDFII,Interleukin-5, IL5, B cell differentiation factor 1, TRF, EDF Isotype Rat IgG1 κ Applications FC , ICC |
- -
- -
Antibody DetailsProduct DetailsReactive Species Mouse Host Species Rat Product Concentration 0.2 mg/ml Formulation This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. Product Preparation Recombinant antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling This Allophycocyanin (APC) conjugate is stable when stored at 2-8°C. Do not freeze. Country of Origin USA Shipping Next Day 2-8°C Excitation Laser Red Laser (650 nm) RRIDAB_2830396 Applications and Recommended Usage? Quality Tested by Leinco Flow Cytometry:This antibody can be used at a concentration of ≤ 0.5 µg per 100 µl of whole blood (or per 1.0 x 106 cells in a 100 µl total staining volume). Each lot of this antibody is quality control tested. Additional Applications Reported In Literature ? Additional reported applications (for the relevant formats) include: ELISA Neutralization Western Blotting IHC-FFPE IHC-FF Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone TRFK5 recognizes mouse/human IL-5. Background IL-5 is a 26 kD TH2 cytokine and a homodimeric glycoprotein that is part of the hematopoietic family. IL-5 stimulates B cell growth as well as increases Ig secretion. It is the main factor that promotes the terminal differentiation of eosinophil progenitors and enhances the effector capacity of mature eosinophils. IL-5 is a major regulator of eosinophil accumulation in tissues. In fact, in Hodgkin lymphoma, the characteristically observed eosinophilia is suspected to result from an increased production of IL-5. IL-5 may also be the cause of several allergic diseases including asthma, where it is thought that eosinophils have a significant role in the disease pathology. There are several mAbs currently in use that target IL-5 for the treatment of severe eosinophilic asthma. Function Growth/differentiation of B cells, eosinophils; proliferation/cell activation/differentiation of eosinophilic granulocytes UniProt.org References & CitationsTechnical Protocols ICC Certificate of Analysis |
Related Products
Formats Available
- -
- -
Prod No. | Description |
|---|---|
I-1314 | |
I-1038 | |
I-1063 | |
I-1313 | |
I-1311 | |
I-1312 | |
I-1064 | |
I-1062 | |
I-1060 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
